Cardisio is a company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases.
Cardisio is a mobile health tech company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases. The Cardisiography test can detect heart disease early, allowing for preventive treatment to avoid a potentially fatal heart attack. Cardisiography analyzes the individual three-dimensional electrophysical profile of the heart and recognizes pathological patterns of heart diseases using a proprietary algorithm and neural networks (AI). The test requires a PC to access the web service (Cardisio Cloud), a data collector (e.g. a Cardisiograph), and commercially available ECG cables as well as five disposable electrodes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 19, 2021 | Seed | €3.50M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jim Davidson | — | Seed |
Shawn O'Neill | — | Seed |